John A. Fallon's most recent trade in Collegium Pharmaceutical Inc was a trade of 34,853 Common Stock done at an average price of $47.2 . Disclosure was reported to the exchange on Nov. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium pharma Inc | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 47.21 per share. | 12 Nov 2025 | 34,853 | 64,634 (0%) | 0% | 47.2 | 1,645,536 | Common Stock |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 19,853 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.33 per share. | 12 Nov 2025 | 19,853 | 99,487 (0%) | 0% | 9.3 | 185,228 | Common Stock |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 15,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.49 per share. | 12 Nov 2025 | 15,000 | 79,634 (0%) | 0% | 16.5 | 247,350 | Common Stock |
| Collegium pharma Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 9,791 | 64,634 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 7,693 | 54,843 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 9,792 | 47,150 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 14,035 | 37,358 (0%) | 0% | 0 | Common Stock | |
| Insulet | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 253.20 per share. | 21 May 2021 | 3,587 | 14,498 (0%) | 0% | 253.2 | 908,246 | Common Stock |
| Insulet | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2021 | 3,587 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.60 per share. | 21 May 2021 | 3,587 | 20,320 (0%) | 0% | 40.6 | 145,632 | Common Stock |
| Insulet | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.87 per share. | 21 May 2021 | 2,235 | 16,733 (0%) | 0% | 28.9 | 64,524 | Common Stock |
| Insulet | John A. Fallon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2021 | 2,235 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet | John A. Fallon | Director | Sale of securities on an exchange or to another person at price $ 253.61 per share. | 21 May 2021 | 2,235 | 18,085 (0%) | 0% | 253.6 | 566,808 | Common Stock |
| Collegium pharma Inc | John A. Fallon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 9,941 | 23,323 (0%) | 0% | 0 | Common Stock |